Thoracic transplant outcomes for idiopathic pulmonary hypertension in children
Idiopathic pulmonary hypertension (IPH) is an indication for lung transplantation (LTx) or combined heart-lung transplantation (HLTx) in the pediatric population. Overall, pulmonary vascular disease is the primary diagnosis for a large minority of children listed for lung transplant, especially those less than 6 years of age.1 However, the relatively low numbers of these surgical procedures performed in children limits accurate outcome data. Previously published work has included study cohorts ranging from 5 to 23 children, severely restricting the ability to predict post-thoracic transplant outcomes based on clinical characteristics.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Richard Hubbard, Rebecca Miller, Dmitry Tumin, Joseph D. Tobias, Don Hayes Tags: Research Correspondence Source Type: research
More News: Cardiology | Children | Heart | Heart Transplant | Hypertension | Lung Transplant | Pediatrics | Pulmonary Hypertension | Study | Transplant Surgery | Transplants